Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Noguchi Memorial Institute for Medical Research | Statement: [University of Ghana, hasInstitute, Noguchi Memorial Institute for Medical Research]

Target entity: Noguchi Memorial Institute for Medical Research
Context triple: [University of Ghana, hasInstitute, Noguchi Memorial Institute for Medical Research]

• A. Institute of Medical Science, University of Tokyo
  The Institute of Medical Science, University of Tokyo is a leading Japanese biomedical research and graduate education center renowned for its work in infectious diseases, genomics, and advanced medical science.
• B. Ibuka Laboratory
  Ibuka Laboratory was an electronics research workshop in postwar Tokyo that became the foundation for what would later grow into Sony.
• C. Kitasato Institute
  The Kitasato Institute is a Japanese medical research and educational organization renowned for its pioneering work in infectious diseases, immunology, and public health.
• D. Nishina Laboratory
  Nishina Laboratory is a pioneering Japanese nuclear and particle physics research facility established in the early 20th century and closely associated with the development of modern physics in Japan.
• E. A. Alfred Taubman Medical Research Institute
  The A. Alfred Taubman Medical Research Institute is a biomedical research center at the University of Michigan dedicated to advancing translational medicine and accelerating the development of new therapies.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Noguchi Memorial Institute for Medical Research
Triple: [University of Ghana, hasInstitute, Noguchi Memorial Institute for Medical Research]

Noguchi Memorial Institute for Medical Research is a leading biomedical research center in Ghana renowned for its work on infectious diseases and public health in West Africa.

Target entity: Noguchi Memorial Institute for Medical Research
Target entity description: Noguchi Memorial Institute for Medical Research is a leading biomedical research center in Ghana renowned for its work on infectious diseases and public health in West Africa.

• A. Institute of Medical Science, University of Tokyo
  The Institute of Medical Science, University of Tokyo is a leading Japanese biomedical research and graduate education center renowned for its work in infectious diseases, genomics, and advanced medical science.
• B. Ibuka Laboratory
  Ibuka Laboratory was an electronics research workshop in postwar Tokyo that became the foundation for what would later grow into Sony.
• C. Kitasato Institute
  The Kitasato Institute is a Japanese medical research and educational organization renowned for its pioneering work in infectious diseases, immunology, and public health.
• D. Nishina Laboratory
  Nishina Laboratory is a pioneering Japanese nuclear and particle physics research facility established in the early 20th century and closely associated with the development of modern physics in Japan.
• E. A. Alfred Taubman Medical Research Institute
  The A. Alfred Taubman Medical Research Institute is a biomedical research center at the University of Michigan dedicated to advancing translational medicine and accelerating the development of new therapies.
• F. None of above. chosen